1. Home
  2. VALN vs MSEX Comparison

VALN vs MSEX Comparison

Compare VALN & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • MSEX
  • Stock Information
  • Founded
  • VALN 2012
  • MSEX 1897
  • Country
  • VALN France
  • MSEX United States
  • Employees
  • VALN N/A
  • MSEX N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • MSEX Water Supply
  • Sector
  • VALN Health Care
  • MSEX Utilities
  • Exchange
  • VALN Nasdaq
  • MSEX Nasdaq
  • Market Cap
  • VALN 820.0M
  • MSEX 963.9M
  • IPO Year
  • VALN 2021
  • MSEX N/A
  • Fundamental
  • Price
  • VALN $9.00
  • MSEX $53.07
  • Analyst Decision
  • VALN Strong Buy
  • MSEX Buy
  • Analyst Count
  • VALN 4
  • MSEX 3
  • Target Price
  • VALN $15.75
  • MSEX $61.67
  • AVG Volume (30 Days)
  • VALN 26.9K
  • MSEX 179.3K
  • Earning Date
  • VALN 11-20-2025
  • MSEX 10-31-2025
  • Dividend Yield
  • VALN N/A
  • MSEX 2.56%
  • EPS Growth
  • VALN N/A
  • MSEX 3.71
  • EPS
  • VALN N/A
  • MSEX 2.39
  • Revenue
  • VALN $230,566,060.00
  • MSEX $194,822,000.00
  • Revenue This Year
  • VALN $6.86
  • MSEX $4.27
  • Revenue Next Year
  • VALN $11.85
  • MSEX $8.65
  • P/E Ratio
  • VALN N/A
  • MSEX $22.25
  • Revenue Growth
  • VALN 25.47
  • MSEX 6.24
  • 52 Week Low
  • VALN $3.62
  • MSEX $44.17
  • 52 Week High
  • VALN $12.25
  • MSEX $70.73
  • Technical
  • Relative Strength Index (RSI)
  • VALN 36.23
  • MSEX 42.17
  • Support Level
  • VALN $9.01
  • MSEX $44.94
  • Resistance Level
  • VALN $9.28
  • MSEX $55.07
  • Average True Range (ATR)
  • VALN 0.22
  • MSEX 2.77
  • MACD
  • VALN -0.11
  • MSEX -0.95
  • Stochastic Oscillator
  • VALN 8.75
  • MSEX 47.17

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

Share on Social Networks: